FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marc De Maeyer

Research Profile

Concepts & Ideas

Phenomena

Protein Binding

Genes & Molecular Sequences

Amino Acid Sequences

Physiology

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Katrien Le Roy; Janka Mátrai; Tom Struyf; Marc De Maeyer; Willem Lammens; Rudy Vergauwen; Shuguang Yuan; Wim Van den Ende
Understanding the role of defective invertases in plants: tobacco Nin88 fails to degrade sucrose.
Thomas Vercruysse; Arnout Voet; Eline Boons; Marc De Maeyer; Jan Steyaert; Els Vanstreels; Tom Venken; Dirk Daelemans
Mapping the Binding Interface between an HIV-1 Inhibiting Intrabody and the Viral Protein Rev.
Rani A Jose; Arnout Voet; Kam Y J Zhang; Katleen Broos; Gilles Bruylants; Marc De Maeyer; Hans Deckmyn; Brecht Egle; Arjen J Jakobi; Wim De Borggraeve
An integrated fragment based screening approach for the discovery of small molecule modulators of the VWF-GPIbα interaction.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marc De Maeyer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Katrien Le Roy; Janka Mátrai; Tom Struyf; Marc De Maeyer; Willem Lammens; Rudy Vergauwen; Shuguang Yuan; Wim Van den Ende
Understanding the role of defective invertases in plants: tobacco Nin88 fails to degrade sucrose.
Plant physiology 2013;161(4):1670-81.
2013: Thomas Vercruysse; Arnout Voet; Eline Boons; Marc De Maeyer; Jan Steyaert; Els Vanstreels; Tom Venken; Dirk Daelemans
Mapping the Binding Interface between an HIV-1 Inhibiting Intrabody and the Viral Protein Rev.
PloS one 2013;8(4):e60259.
2012: Rani A Jose; Arnout Voet; Kam Y J Zhang; Katleen Broos; Gilles Bruylants; Marc De Maeyer; Hans Deckmyn; Brecht Egle; Arjen J Jakobi; Wim De Borggraeve
An integrated fragment based screening approach for the discovery of small molecule modulators of the VWF-GPIbα interaction.
Chemical communications (Cambridge, England) 2012;48(92):11349-51.
2012: Christine Helsen; Mieke Trekels; Renée Vancraenenbroeck; Annelien Verfaillie; Jacques Young; Marc De Maeyer; Vanessa Dubois; Frank Claessens
Evidence for DNA-binding domain--ligand-binding domain communications in the androgen receptor.
Molecular and cellular biology 2012;32(15):3033-43.
2012: Tom Venken; Dirk Daelemans; Marc De Maeyer; Arnout Voet
Computational investigation of the HIV-1 Rev multimerization using molecular dynamics simulations and binding free energy calculations.
Proteins 2012;80(6):1633-46.
2012: Katleen Broos; Wim De Borggraeve; Hans Deckmyn; Jonas Demeulemeester; Brecht Egle; Rani Alphonsa Jose; Mieke Trekels; Aline Vandenbulcke; Nele Vandeputte; Tom Venken; Marc De Maeyer
Identification of a small molecule that modulates platelet glycoprotein Ib-von Willebrand factor interaction.
The Journal of biological chemistry 2012;287(12):9461-72.
2012: Renée Vancraenenbroeck; Stephen D Weeks; Veerle Baekelandt; Evy Lobbestael; Sergei V Strelkov; Jean-Marc Taymans; Marc De Maeyer
Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2.
Biochimica et biophysica acta 2012;1824(3):450-60.
2012: G Monaco; H De Smedt; R Ponsaerts; Marc De Maeyer; C W Distelhorst; L Leybaert; E Decrock; L Missiaen; T Vervliet; J B Parys; T Luyten; H Akl; G Bultynck
Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl.
Cell death and differentiation 2012;19(2):295-309.
2012: Laura Civiero; Mark Cookson; Marc De Maeyer; Fangye Gao; Elisa Greggio; Evy Lobbestael; Ivan Micetic; Lauran Reyniers; Veerle Baekelandt; Alexandra Beilina; Elisa Belluzzi; Luigi Bubacco; Renée Vancraenenbroeck; Jean-Marc Taymans
Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers.
PloS one 2012;7(8):e43472.
2012: Shuguang Yuan; Willem Lammens; Katrien Le Roy; Wim Van den Ende; Tom Venken; Marc De Maeyer
pKa modulation of the acid/base catalyst within GH32 and GH68: a role in substrate/inhibitor specificity?
PloS one 2012;7(5):e37453.
2011: Tom Venken; Marc De Maeyer; Petra Henklein; Frank Kirchhoff; Daniela Krnavek; Jan Münch; Arnout Voet
An optimized MM/PBSA virtual screening approach applied to an HIV-1 gp41 fusion peptide inhibitor.
Proteins 2011;79(11):3221-35.
2011: Arnout Voet; Leen Callewaert; Tim Ulens; Lise Vanderkelen; Joris M Vanherreweghe; Chris W Michiels; Marc De Maeyer
Structure based discovery of small molecule suppressors targeting bacterial lysozyme inhibitors.
Biochemical and biophysical research communications 2011;405(4):527-32.
2011: Jean-Marc Taymans; Renée Vancraenenbroeck; Veerle Baekelandt; Alexandra Beilina; Marc De Maeyer; Evy Lobbestael; Petri Ollikainen; Mark Cookson
LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding.
PloS one 2011;6(8):e23207.
2011: Veronique Daniëls; Renée Vancraenenbroeck; Bernard M H Law; Elisa Greggio; Evy Lobbestael; Fangye Gao; Marc De Maeyer; Mark Cookson; Kirsten Harvey; Veerle Baekelandt; Jean-Marc Taymans
Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant.
Journal of neurochemistry 2011;116(2):304-15.
2010: Frauke Christ; Arnout Voet; Arnaud Marchand; Stefan Nicolet; Belete Ayele Desimmie; Damien Marchand; Dorothée Bardiot; Nam Joo Van der Veken; Barbara Van Remoortel; Sergei V Strelkov; Marc De Maeyer; Patrick Chaltin; zeger debyser
Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication.
Nature chemical biology 2010;6(6):442-8.
2009: Hendrik B Feys; Inge Pareyn; Renee Vancraenenbroeck; Marc De Maeyer; Hans Deckmyn; Chris Van Geet; Karen Vanhoorelbeke
Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease domain reduces secretion and substrate turnover in a patient with congenital thrombotic thrombocytopenic purpura.
Blood 2009;114(21):4749-52.
2009: Ilse Vandecaetsbeek; Mieke Trekels; Marc De Maeyer; Hugo Ceulemans; Eveline Lescrinier; Luc Raeymaekers; Frank Wuytack; Peter Vangheluwe
Structural basis for the high Ca2+ affinity of the ubiquitous SERCA2b Ca2+ pump.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(44):18533-8.
2009: P Nataraj Sekhar; L Ananda Reddy; Marc De Maeyer; K Praveen Kumar; Y S Srinivasulu; M S L Sunitha; I S N Sphoorthi; G Jayasree; A Maruthi Rao; V S Kothekar; P V B S Narayana; P B Kavi Kishor
Genome wide analysis and comparative docking studies of new diaryl furan derivatives against human cyclooxygenase-2, lipoxygenase, thromboxane synthase and prostacyclin synthase enzymes involved in inflammatory pathway.
Journal of molecular graphics & modelling 2009;28(4):313-29.
2009: Samuel L C Moors; Abel Jonckheer; Marc De Maeyer; Yves Engelborghs; Arnout Ceulemans
Tryptophan conformations associated with partial unfolding in ribonuclease T1.
Biophysical journal 2009;97(6):1778-86.
2009: Krassimira Idakieva; Nurul Islam Siddiqui; Filip Meersman; Marc De Maeyer; Irena Chakarska; Constant Gielens
Influence of limited proteolysis, detergent treatment and lyophilization on the phenoloxidase activity of Rapana thomasiana hemocyanin.
International journal of biological macromolecules 2009;45(2):181-7.
2009: Ellen Fierens; Kurt Gebruers; Arnout Voet; Marc De Maeyer; Christophe M Courtin; Jan A Delcour
Biochemical and structural characterization of TLXI, the Triticum aestivum L. thaumatin-like xylanase inhibitor.
Journal of enzyme inhibition and medicinal chemistry 2009;24(3):646-54.
2009: Sigrid Rombouts; Ellen Fierens; elien vandermarliere; Arnout Voet; Kurt Gebruers; Johnny Beaugrand; Christophe M Courtin; Jan A Delcour; Marc De Maeyer; Anja Rabijns; Steven Van Campenhout; Guido Volckaert
His22 of TLXI plays a critical role in the inhibition of glycoside hydrolase family 11 xylanases.
Journal of enzyme inhibition and medicinal chemistry 2009;24(1):38-46.
2008: K Hillmayer; R Vancraenenbroeck; Marc De Maeyer; Griet Compernolle; Paul J Declerck; Ann Gils
Discovery of novel mechanisms and molecular targets for the inhibition of activated thrombin activatable fibrinolysis inhibitor.
Journal of thrombosis and haemostasis : JTH 2008;6(11):1892-9.
2008: Janka Mátrai; Abel Jonckheer; Eddy Joris; Peter Krüger; Eric Carpenter; Jack Tuszynski; Marc De Maeyer; Yves Engelborghs
Exploration of the activation pathway of Deltaalpha-Chymotrypsin with molecular dynamics simulations and correlation with kinetic experiments.
European biophysics journal : EBJ 2008;38(1):13-23.
2008: Samuel L C Moors; Abel Jonckheer; Marc De Maeyer; Yves Engelborghs; Arnout Ceulemans
How do rotameric conformations influence the time-resolved fluorescence of tryptophan in proteins? A perspective based on molecular modeling and quantum chemistry.
Current protein & peptide science 2008;9(5):427-46.
2008: Jean-Marie Zimmer; François Roman; Christine Lambert; Abel Jonckheer; Ana Vazquez; Jean-Marc Plesséria; Jean-Yves Servais; Kris Covens; Jan Weber; Kristel Van Laethem; Jean-Claude Schmit; Anne-Mieke Vandamme; Miguel E Quinones-Mateu; Marc De Maeyer
Impact on replicative fitness of the G48E substitution in the protease of HIV-1: an in vitro and in silico evaluation.
Journal of acquired immune deficiency syndromes (1999) 2008;48(3):255-62.
2008: Anneleen Hombrouck; Arnout Voet; Barbara Van Remoortel; Christel Desadeleer; Marc De Maeyer; zeger debyser; Myriam Witvrouw
Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137.
Antimicrobial agents and chemotherapy 2008;52(6):2069-78.
2008: Janka Mátrai; Willem Lammens; Abel Jonckheer; Katrien Le Roy; Anja Rabijns; Wim Van den Ende; Marc De Maeyer
An alternate sucrose binding mode in the E203Q Arabidopsis invertase mutant: an X-ray crystallography and docking study.
Proteins 2008;71(2):552-64.
2008: Giovanni Maglia; Abel Jonckheer; Marc De Maeyer; Jean-Marie Frère; Yves Engelborghs
An unusual red-edge excitation and time-dependent Stokes shift in the single tryptophan mutant protein DD-carboxypeptidase from Streptomyces: the role of dynamics and tryptophan rotamers.
Protein science : a publication of the Protein Society 2008;17(2):352-61.
2008: H P L Steenackers; J C Janssens; J Levin; Arnout Voet; Marc De Maeyer; Dirk E De Vos; Jos Vanderleyden; S J C De Keersmaecker
Inhibition of salmonella biofilm formation: a sustainable alternative in the production of safe and healthy food.
Communications in agricultural and applied biological sciences 2008;73(1):71-6.
2007: Erik Ceresa; Marc De Maeyer; A Jonckheer; Miet Peeters; Yves Engelborghs; Paul J Declerck; Ann Gils
Comparative evaluation of stable TAFIa variants: importance of alpha-helix 9 and beta-sheet 11 for TAFIa (in)stability.
Journal of thrombosis and haemostasis : JTH 2007;5(10):2105-12.
2007: Hector Novoa de Armas; Maarten Dewilde; Koen Verbeke; Marc De Maeyer; Paul J Declerck
Study of recombinant antibody fragments and PAI-1 complexes combining protein-protein docking and results from site-directed mutagenesis.
Structure (London, England : 1993) 2007;15(9):1105-16.
2007: alexandre fontayne; Bauke De Maeyer; Marc De Maeyer; Mayo Yamashita; Tadashi Matsushita; Hans Deckmyn
Paratope and epitope mapping of the antithrombotic antibody 6B4 in complex with platelet glycoprotein Ibalpha.
The Journal of biological chemistry 2007;282(32):23517-24.
2007: Constant Gielens; Krassimira Idakieva; Marc De Maeyer; Viviane Van den Bergh; Nurul Islam Siddiqui; Frans Compernolle
Conformational stabilization at the active site of molluskan (Rapana thomasiana) hemocyanin by a cysteine-histidine thioether bridge A study by mass spectrometry and molecular modeling.
Peptides 2007;28(4):790-7.
2007: Anneleen Hombrouck; Jan De Rijck; Jelle Hendrix; Linos Vandekerckhove; Arnout Voet; Marc De Maeyer; Myriam Witvrouw; Yves Engelborghs; Frauke Christ; Rik Gijsbers; zeger debyser
Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV.
PLoS pathogens 2007;3(3):e47.
2007: Javier Pérez Moreno; Inge Asselberghs; Kai Song; Koen Clays; Yuxia Zhao; Hachiro Nakanishi; Shuji Okada; Kyoko Nogi; Oh-Kil Kim; Jongtae Je; Janka Mátrai; Marc De Maeyer; Mark G Kuzyk
Combined molecular and supramolecular bottom-up nanoengineering for enhanced nonlinear optical response: experiments, modeling, and approaching the fundamental limit.
The Journal of chemical physics 2007;126(7):074705.
2007: Katrien Busschots; Arnout Voet; Marc De Maeyer; Jean-Christophe Rain; Stéphane Emiliani; Richard Benarous; Linda Desender; zeger debyser; Frauke Christ
Identification of the LEDGF/p75 binding site in HIV-1 integrase.
Journal of molecular biology 2007;365(5):1480-92.
2006: Samuel L C Moors; Mario Hellings; Marc De Maeyer; Yves Engelborghs; Arnout Ceulemans
Tryptophan rotamers as evidenced by X-ray, fluorescence lifetimes, and molecular dynamics modeling.
Biophysical journal 2006;91(3):816-23.
2006: Stephanie Staelens; Michael A Hadders; Stephan Vauterin; Céline Platteau; Marc De Maeyer; Karen Vanhoorelbeke; Eric G Huizinga; Hans Deckmyn
Paratope determination of the antithrombotic antibody 82D6A3 based on the crystal structure of its complex with the von Willebrand factor A3-domain.
The Journal of biological chemistry 2006;281(4):2225-31.
2004: Mario Hellings; Yves Engelborghs; Hans Deckmyn; Karen Vanhoorelbeke; Marion E Schiphorst; Jan-Willem N Akkerman; Marc De Maeyer
Experimental indication for the existence of multiple Trp rotamers in von Willebrand Factor A3 domain.
Proteins 2004;57(3):596-601.
2004: Valery Fikkert; Anneleen Hombrouck; Barbara Van Remoortel; Marc De Maeyer; Christophe Pannecouque; Erik De Clercq; zeger debyser; Myriam Witvrouw
Multiple mutations in human immunodeficiency virus-1 integrase confer resistance to the clinical trial drug S-1360.
AIDS (London, England) 2004;18(15):2019-28.
2004: Ken R F Somers; Peter Krüger; Sylwia Bucikiewicz; Marc De Maeyer; Yves Engelborghs; Arnout Ceulemans
Protein simulations: the absorption spectrum of barnase point mutants.
Protein science : a publication of the Protein Society 2004;13(7):1823-31.
2004: Jean-Guy G Gilles; Sabrina Grailly; Marc De Maeyer; Marc Jacquemin; Luc VanderElst; Jean-Marie Saint-Remy
In vivo neutralization of a C2 domain-specific human anti-Factor VIII inhibitor by an anti-idiotypic antibody.
Blood 2004;103(7):2617-23.
2003: Valery Fikkert; Bénédicte Van Maele; Jo Vercammen; Anke Hantson; Barbara Van Remoortel; Martine Michiels; Cristina Gurnari; Christophe Pannecouque; Marc De Maeyer; Yves Engelborghs; Erik De Clercq; zeger debyser; Myriam Witvrouw
Development of resistance against diketo derivatives of human immunodeficiency virus type 1 by progressive accumulation of integrase mutations.
Journal of virology 2003;77(21):11459-70.
2003: Karen Vanhoorelbeke; Hilde Depraetere; Roland A Romijn; Eric G Huizinga; Marc De Maeyer; Hans Deckmyn
A consensus tetrapeptide selected by phage display adopts the conformation of a dominant discontinuous epitope of a monoclonal anti-VWF antibody that inhibits the von Willebrand factor-collagen interaction.
The Journal of biological chemistry 2003;278(39):37815-21.
2003: Mario Hellings; Marc De Maeyer; Stefan Verheyden; Qiang Hao; Els J M Van Damme; Willy J Peumans; Yves Engelborghs
The dead-end elimination method, tryptophan rotamers, and fluorescence lifetimes.
Biophysical journal 2003;85(3):1894-902.
2003: Marc Jacquemin; Marc De Maeyer; Roseline d'Oiron; Renaud Lavend'homme; Kathelijne Peerlinck; Jean-Marie Saint-Remy
Molecular mechanisms of mild and moderate hemophilia A.
Journal of thrombosis and haemostasis : JTH 2003;1(3):456-63.
2002: Hugo Ceulemans; Veerle Vulsteke; Marc De Maeyer; Kelly Tatchell; Willy Stalmans; Mathieu Bollen
Binding of the concave surface of the Sds22 superhelix to the alpha 4/alpha 5/alpha 6-triangle of protein phosphatase-1.
The Journal of biological chemistry 2002;277(49):47331-7.
2002: Petra A M Warmerdam; Stephane Plaisance; Kristel Vanderlick; Petra Vandervoort; Kathleen Brepoels; Désiré Collen; Marc De Maeyer
Elimination of a human T-cell region in staphylokinase by T-cell screening and computer modeling.
Thrombosis and haemostasis 2002;87(4):666-73.
2002: Christel Verboven; Anja Rabijns; Marc De Maeyer; Hugo Van Baelen; Roger Bouillon; Camiel J De Ranter
A structural basis for the unique binding features of the human vitamin D-binding protein.
Nature structural biology 2002;9(2):131-6.
2002: Petra A M Warmerdam; Kristel Vanderlick; Petra Vandervoort; Heidi De Smedt; Stephane Plaisance; Marc De Maeyer; Désiré Collen
Staphylokinase-specific cell-mediated immunity in humans.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(1):155-61.
2001: B Arza; Marc De Maeyer; Jordi Félez; Désiré Collen; H Roger Lijnen
Critical role of glutamic acid 202 in the enzymatic activity of stromelysin-1 (MMP-3).
European journal of biochemistry / FEBS 2001;268(3):826-31.
2000: Désiré Collen; Peter Sinnaeve; E Demarsin; H Moreau; Marc De Maeyer; L Jespers; Yves Laroche; Frans Van de Werf
Polyethylene glycol-derivatized cysteine-substitution variants of recombinant staphylokinase for single-bolus treatment of acute myocardial infarction.
Circulation 2000;102(15):1766-72.
2000: Johan Desmet; Marc De Maeyer; J Spriet; Ignace Lasters
Flexible docking of peptide ligands to proteins.
Methods in molecular biology (Clifton, N.J.) 2000;143():359-76.
2000: Marc De Maeyer; Johan Desmet; Ignace Lasters
The dead-end elimination theorem: mathematical aspects, implementation, optimizations, evaluation, and performance.
Methods in molecular biology (Clifton, N.J.) 2000;143():265-304.
1999: Hugo Ceulemans; Marc De Maeyer; Willy Stalmans; Mathieu Bollen
A capping domain for LRR protein interaction modules.
FEBS letters 1999;456(3):349-51.
1999: L Jespers; H Roger Lijnen; S Vanwetswinkel; Berthe Van Hoef; Kathleen Brepoels; Désiré Collen; Marc De Maeyer
Guiding a docking mode by phage display: selection of correlated mutations at the staphylokinase-plasmin interface.
Journal of molecular biology 1999;290(2):471-9.
1999: L Jespers; S Vanwetswinkel; H Roger Lijnen; N Van Herzeele; Berthe Van Hoef; E Demarsin; Désiré Collen; Marc De Maeyer
Structural and functional basis of plasminogen activation by staphylokinase.
Thrombosis and haemostasis 1999;81(4):479-85.
1998: L Jespers; N Van Herzeele; H Roger Lijnen; Berthe Van Hoef; Marc De Maeyer; Désiré Collen; Ignace Lasters
Arginine 719 in human plasminogen mediates formation of the staphylokinase:plasmin activator complex.
Biochemistry 1998;37(18):6380-6.
1997: Ignace Lasters; Johan Desmet; Marc De Maeyer
Dead-end based modeling tools to explore the sequence space that is compatible with a given scaffold.
Journal of protein chemistry 1997;16(5):449-52.
1997: Johan Desmet; I A Wilson; M Joniau; Marc De Maeyer; Ignace Lasters
Computation of the binding of fully flexible peptides to proteins with flexible side chains.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1997;11(2):164-72.
1997: Aftab Rashid; Marie-Louise Van Hauwaert; M Haque; A H Siddiqi; Ignace Lasters; Marc De Maeyer; Nathalie Griffon; Michael C Marden; Sylvia Dewilde; J Clauwaert; Serge N Vinogradov; Luc Moens
Trematode myoglobins, functional molecules with a distal tyrosine.
The Journal of biological chemistry 1997;272(5):2992-9.
1997: Johan Desmet; Marc De Maeyer; Ignace Lasters
Theoretical and algorithmical optimization of the dead-end elimination theorem.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 1997;():122-33.
1997: Marc De Maeyer; Johan Desmet; Ignace Lasters
All in one: a highly detailed rotamer library improves both accuracy and speed in the modelling of sidechains by dead-end elimination.
Folding & design 1997;2(1):53-66.
1995: Ignace Lasters; Marc De Maeyer; Johan Desmet
Enhanced dead-end elimination in the search for the global minimum energy conformation of a collection of protein side chains.
Protein engineering 1995;8(8):815-22.
1995: M S Lim-Wilby; K Hallenga; Marc De Maeyer; Ignace Lasters; G P Vlasuk; TK Brunck
NMR structure determination of tick anticoagulant peptide (TAP).
Protein science : a publication of the Protein Society 1995;4(2):178-86.
1992: A M Lambeir; M Lauwereys; P Stanssens; Nadir Mrabet; J Snauwaert; H van Tilbeurgh; G Matthyssens; Ignace Lasters; Marc De Maeyer; Shoshana J Wodak
Protein engineering of xylose (glucose) isomerase from Actinoplanes missouriensis. 2. Site-directed mutagenesis of the xylose binding site.
Biochemistry 1992;31(24):5459-66.
1992: J Jenkins; Joël Janin; F Rey; M Chiadmi; H van Tilbeurgh; Ignace Lasters; Marc De Maeyer; D Van Belle; Shoshana J Wodak; M Lauwereys
Protein engineering of xylose (glucose) isomerase from Actinoplanes missouriensis. 1. Crystallography and site-directed mutagenesis of metal binding sites.
Biochemistry 1992;31(24):5449-58.
1992: J Desmet; Marc De Maeyer; B Hazes; I Lasters
The dead-end elimination theorem and its use in protein side-chain positioning.
Nature 1992;356(6369):539-42.
1992: J P Scheerlinck; Ignace Lasters; M Claessens; Marc De Maeyer; frederic pio; P Delhaise; Shoshana J Wodak
Recurrent alpha beta loop structures in TIM barrel motifs show a distinct pattern of conserved structural features.
Proteins 1992;12(4):299-313.
1989: Jan Tavernier; X van Ostade; G Hauquier; T Prange; Ignace Lasters; Marc De Maeyer; Anita Lewit-Bentley; Roger Fourme
Conserved residues of tumour necrosis factor and lymphotoxin constitute the framework of the trimeric structure.
FEBS letters 1989;257(2):315-8.
1984: L J Lijk; C A Torfs; K H Kalk; Marc De Maeyer; W G Hol
Differences in the binding of sulfate, selenate and thiosulfate ions to bovine liver rhodanese, and a description of a binding site for ammonium and sodium ions. An X-ray diffraction study.
European journal of biochemistry / FEBS 1984;142(2):399-408.
1979: L Hellemans; Marc De Maeyer; R Ooms
Dielectric perturbation of hydrogen-bonded systems by high electric fields [proceedings].
Archives internationales de physiologie et de biochimie 1979;87(5):1009.